Singapore O&G

SINGAPORE (May 9): Singapore O&G (SOG) has reported earnings of $2.1 million for 1Q19, down 15.5% from $2.5 million a year ago due to higher operational expenses.

SINGAPORE (Mar 6): Singapore O&G, the chain of medical practices specialising in women's health mainly in obstetrics and gynaecology (O&G), has agreed to a settlement amount of $1.25 million from its former lead independent director, Christopher Chong

SINGAPORE (Nov 9): DBS Vickers Securities has upgraded its view on Singapore O&G (SOG) to “neutral” from “fully valued” while raising its target price on the healthcare stock to 52 cents from 41 cents previously, which is pegged to 25 times P/E on

SINGAPORE (Oct 3): Singapore O&G has entered into a service agreement with KL Fertility & Gynaecology Centre for the latter to provide Assisted Reproductive Technology (ART) services to its patients.

SINGAPORE (Sept 27): New entrants UnUsUaL and Kimly now maintain the two highest weights on the FTSE ST Catalist Index, at 6% and 5% respectively.

SINGAPORE (Aug 11): DBS is staying positive on Singapore O&G’s medium-term growth potential but the research house is cautious on the near-term potential headwinds.

SINGAPORE (Aug 10): Singapore O&G, the specialist in women’s and children’s healthcare, announced 1H17 earnings fell 6.4% to $4.1 million from $4.4 million a year ago.

SINGAPORE (May 22): Healthcare stocks in Singapore have rewarded investors with an average 50% gain in the past year, a rally that may continue as companies acquire local clinics to expand in the region’s medical-care market.

SINGAPORE (May 16): DBS is maintaining its “buy” call on Singapore O&G with adjusted-for-share-split target price of 80 cents on positive growth prospects even though it has had a slow start.

SINGAPORE (April 17): UOB Kay Hian is maintaining a “buy” call on Singapore O&G with higher target price of $1.53 on expectations paediatrics service could start in 2H17.